Cite
HARVARD Citation
Mo, D. et al. (2023). Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma. Lancet oncology. 24 (1), pp. e7-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mo, D. et al. (2023). Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma. Lancet oncology. 24 (1), pp. e7-. [Online].